Literature DB >> 9637133

Serum insulin-like growth factor-I levels and prostate cancer risk--interpreting the evidence.

P Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9637133     DOI： 10.1093/jnci/90.12.876

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  11 in total

1.  Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

Authors:  Mari-Anne Rowlands; Jeff M P Holly; David Gunnell; Jenny Donovan; J Athene Lane; Freddie Hamdy; David E Neal; Steven Oliver; George Davey Smith; Richard M Martin
Journal:  Cancer Res       Date:  2011-11-21       Impact factor: 12.701

Review 2.  Growth hormone and prostate cancer: guilty by association?

Authors:  A Grimberg; P Cohen
Journal:  J Endocrinol Invest       Date:  1999       Impact factor: 4.256

3.  Relationships between IGF-1 and IGFBP-1 and adiposity in obese African-American and Latino adolescents.

Authors:  Tanya L Alderete; Courtney E Byrd-Williams; Claudia M Toledo-Corral; David V Conti; Marc J Weigensberg; Michael I Goran
Journal:  Obesity (Silver Spring)       Date:  2010-09-30       Impact factor: 5.002

Review 4.  Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.

Authors:  Ganna Chornokur; Kyle Dalton; Meghan E Borysova; Nagi B Kumar
Journal:  Prostate       Date:  2010-12-28       Impact factor: 4.104

Review 5.  Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.

Authors:  A Grimberg; P Cohen
Journal:  J Cell Physiol       Date:  2000-04       Impact factor: 6.384

6.  Influence of gender on serum growth hormone, insulin-like growth factor-I and its binding protein-3 during aging.

Authors:  Chiou-Meei Lin; Yeou-Lih Huang; Zu-Yau Lin
Journal:  Yonsei Med J       Date:  2009-06-24       Impact factor: 2.759

7.  Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups.

Authors:  Prevathe Poniah; Zahurin Mohamed; Yamunah Devi Apalasamy; Shamsul Mohd Zain; Shanggar Kuppusamy; Azad Ha Razack
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Murine osteosarcoma primary tumour growth and metastatic progression is maintained after marked suppression of serum insulin-like growth factor I.

Authors:  Sung-Hyeok Hong; Joseph Briggs; Rachel Newman; Karen Hoffman; Arnulfo Mendoza; Derek LeRoith; Lee Helman; Shoshana Yakar; Chand Khanna
Journal:  Int J Cancer       Date:  2009-05-01       Impact factor: 7.396

9.  Commentary: prostate cancer is omnipresent, but should we screen for it?

Authors:  Richard M Martin
Journal:  Int J Epidemiol       Date:  2007-04       Impact factor: 7.196

10.  Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.

Authors:  Carolina Bonilla; Sarah J Lewis; Mari-Anne Rowlands; Tom R Gaunt; George Davey Smith; David Gunnell; Tom Palmer; Jenny L Donovan; Freddie C Hamdy; David E Neal; Rosalind Eeles; Doug Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch; Kenneth Muir; Graham G Giles; Fredrik Wiklund; Henrik Grönberg; Christopher A Haiman; Johanna Schleutker; Børge G Nordestgaard; Ruth C Travis; Nora Pashayan; Kay-Tee Khaw; Janet L Stanford; William J Blot; Stephen Thibodeau; Christiane Maier; Adam S Kibel; Cezary Cybulski; Lisa Cannon-Albright; Hermann Brenner; Jong Park; Radka Kaneva; Jyotsna Batra; Manuel R Teixeira; Hardev Pandha; Mark Lathrop; Richard M Martin; Jeff M P Holly
Journal:  Int J Cancer       Date:  2016-06-23       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.